Cargando…
Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors
Checkpoint inhibitor (CPI) therapy has only recently been introduced in the first-line treatment of advanced gastric cancer. However, later line monotherapy CPI efficacy in a subset of patients was presented about four years prior. Here, we present three cases of advanced gastric adenocarcinoma canc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149843/ https://www.ncbi.nlm.nih.gov/pubmed/35645245 http://dx.doi.org/10.3390/diseases10020024 |
_version_ | 1784717290484269056 |
---|---|
author | Kaakour, Dalia Ward, Garrett Dayyani, Farshid |
author_facet | Kaakour, Dalia Ward, Garrett Dayyani, Farshid |
author_sort | Kaakour, Dalia |
collection | PubMed |
description | Checkpoint inhibitor (CPI) therapy has only recently been introduced in the first-line treatment of advanced gastric cancer. However, later line monotherapy CPI efficacy in a subset of patients was presented about four years prior. Here, we present three cases of advanced gastric adenocarcinoma cancers treated with CPI in early lines years prior to the availability of randomized first line data. All three patients remain in remission without gastrectomy, with the median time from initial diagnosis of approximately 52 months. With long-term follow-up of more than four years, we present a proof of concept that, with early integration of CPI therapy, highly durable responses are possible even in the absence of surgery in patients with advanced gastric and gastroesophageal junction cancers. |
format | Online Article Text |
id | pubmed-9149843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91498432022-05-31 Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors Kaakour, Dalia Ward, Garrett Dayyani, Farshid Diseases Brief Report Checkpoint inhibitor (CPI) therapy has only recently been introduced in the first-line treatment of advanced gastric cancer. However, later line monotherapy CPI efficacy in a subset of patients was presented about four years prior. Here, we present three cases of advanced gastric adenocarcinoma cancers treated with CPI in early lines years prior to the availability of randomized first line data. All three patients remain in remission without gastrectomy, with the median time from initial diagnosis of approximately 52 months. With long-term follow-up of more than four years, we present a proof of concept that, with early integration of CPI therapy, highly durable responses are possible even in the absence of surgery in patients with advanced gastric and gastroesophageal junction cancers. MDPI 2022-04-24 /pmc/articles/PMC9149843/ /pubmed/35645245 http://dx.doi.org/10.3390/diseases10020024 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Kaakour, Dalia Ward, Garrett Dayyani, Farshid Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors |
title | Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors |
title_full | Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors |
title_fullStr | Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors |
title_full_unstemmed | Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors |
title_short | Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors |
title_sort | early adoption of checkpoint inhibitors in patients with metastatic gastric adenocarcinoma—a case series of non-operative long-term survivors |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149843/ https://www.ncbi.nlm.nih.gov/pubmed/35645245 http://dx.doi.org/10.3390/diseases10020024 |
work_keys_str_mv | AT kaakourdalia earlyadoptionofcheckpointinhibitorsinpatientswithmetastaticgastricadenocarcinomaacaseseriesofnonoperativelongtermsurvivors AT wardgarrett earlyadoptionofcheckpointinhibitorsinpatientswithmetastaticgastricadenocarcinomaacaseseriesofnonoperativelongtermsurvivors AT dayyanifarshid earlyadoptionofcheckpointinhibitorsinpatientswithmetastaticgastricadenocarcinomaacaseseriesofnonoperativelongtermsurvivors |